BioInvent International AB (publ)

BioInvent International AB (publ) - Current Ratioverified

0H22.L

Founded in 1996 and based in Lund, Sweden, BioInvent International AB (publ) is a clinical-stage biotechnology company dedicated to the discovery, research, and development of immuno-modulatory antibodies for cancer treatment. Its operations span Sweden, Europe, the United States, Japan, and other global regions. The company's leading therapeutic candidate, BI-1206, is under development for non-Hodgkin lymphoma and various solid tumors. BioInvent's pipeline also features projects targeting tumor-associated myeloid cells and cancer-associated regulatory T cells, which play a role in modulating the immune system. Other notable developments include BT-001 for solid tumors, and the anti-TNFR2 an...[Read more]

Industry

Biotechnology

IPO Date

2008-02-27

Stock Exchange

LSE

Ticker

0H22.L

The Current Ratio as of August 2026 (TTM) for BioInvent International AB (publ) (0H22.L) is 5.32

According to BioInvent International AB (publ)’s latest financial reports and current stock price. The company's current Current Ratio is 5.32. This represents a change of -21.16% compared to the average of 6.74 of the last 4 quarters.

BioInvent International AB (publ) (0H22.L) Historical Current Ratio (quarterly & annually)

How has 0H22.L Current Ratio performed in the past?

The mean historical Current Ratio of BioInvent International AB (publ) over the last ten years is 9.33. The current 5.32 Current Ratio has changed 5.60% with respect to the historical average. Over the past ten years (40 quarters), 0H22.L's Current Ratio was at its highest in in the June 2021 quarter at 27.99. The Current Ratio was at its lowest in in the March 2019 quarter at 2.73.

Quarterly (TTM)
Annual

Average

9.33

Median

7.90

Minimum

3.12

Maximum

18.98

BioInvent International AB (publ) (0H22.L) Current Ratio by Quarter and Year

Discovering the peaks and valleys of BioInvent International AB (publ) Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 253.14%

Maximum Annual Current Ratio = 18.98

Minimum Annual Increase = -42.75%

Minimum Annual Current Ratio = 3.12

Quarterly (TTM)
Annual
YearCurrent RatioChange
20255.67-42.75%
20249.91-33.63%
202314.9320.24%
202212.41-34.60%
202118.9831.39%
202014.45253.14%
20194.0931.00%
20183.12-17.53%
20173.79-35.83%
20165.90177.65%

BioInvent International AB (publ) (0H22.L) Average Current Ratio

How has 0H22.L Current Ratio performed in the past?

The current Current Ratio of BioInvent International AB (publ) (0H22.L) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

10.17

5-year avg

12.38

10-year avg

9.33

BioInvent International AB (publ) (0H22.L) Current Ratio vs. Peers

How is 0H22.L’s Current Ratio compared to its peers?

BioInvent International AB (publ)’s Current Ratio is greater than Hansa Biopharma AB (publ) (1.25), greater than Humana AB (publ) (0.62), less than Probi AB (publ) (6.94), greater than Bactiguard Holding AB (publ) (1.65), greater than Ambea AB (publ) (0.45),

Build a custom stock screener for BioInvent International AB (publ) (0H22.L) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BioInvent International AB (publ) using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

BioInvent International AB (publ) (0H22.L) and other stocks custom spreadsheet templates

The easiest way to analyze a company like BioInvent International AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is BioInvent International AB (publ)'s Current Ratio?

How is the Current Ratio calculated for BioInvent International AB (publ) (0H22.L)?

What is the highest Current Ratio for BioInvent International AB (publ) (0H22.L)?

What is the 3-year average Current Ratio for BioInvent International AB (publ) (0H22.L)?

What is the 5-year average Current Ratio for BioInvent International AB (publ) (0H22.L)?

How does the current Current Ratio for BioInvent International AB (publ) (0H22.L) compare to its historical average?